Literature DB >> 19961450

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.

Salvatore L Ruggiero1, Thomas B Dodson, Leon A Assael, Regina Landesberg, Robert E Marx, Bhoomi Mehrotra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19961450     DOI： 10.1111/j.1747-4477.2009.00213.x

Source DB:  PubMed          Journal:  Aust Endod J        ISSN： 1329-1947            Impact factor:   1.659


× No keyword cloud information.
  70 in total

Review 1.  The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

Authors:  Samantha Pozzi; Noopur Raje
Journal:  Oncologist       Date:  2011-04-14

Review 2.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

3.  Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

Authors:  Meral Günaldi; Cigdem Usul Afsar; Berna Bozkurt Duman; Ismail Oguz Kara; Ufuk Tatli; Berksoy Sahin
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

Review 4.  Pre- and postoperative management techniques. Before and after. Part 1: medical morbidities.

Authors:  J Mansoor
Journal:  Br Dent J       Date:  2015-03-13       Impact factor: 1.626

5.  Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.

Authors:  Akihiko Matsumoto; Masanori Sasaki; Rainer Schmelzeisen; Yukiko Oyama; Yoshihide Mori; Pit Jacob Voss
Journal:  Clin Oral Investig       Date:  2016-02-29       Impact factor: 3.573

6.  Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Authors:  J Ignacio Aguirre; Mohammed P Akhter; Donald B Kimmel; Jennifer E Pingel; Alyssa Williams; Marda Jorgensen; Lakshmyya Kesavalu; Thomas J Wronski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

7.  Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Giulio Giannelli; Gloria Denotti; Germano Orrù
Journal:  Open Dent J       Date:  2013-08-23

8.  Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities.

Authors:  Konstantinos T Mitsimponas; Patrick Moebius; Kerstin Amann; Philipp Stockmann; Karl-Andreas Schlegel; Friedrich-Wilhelm Neukam; Falk Wehrhan
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

10.  A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.

Authors:  Bevin C English; Caitlin E Baum; David E Adelberg; Tristan M Sissung; Paul G Kluetz; William L Dahut; Douglas K Price; William D Figg
Journal:  Ther Clin Risk Manag       Date:  2010-11-19       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.